Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 14 (5), 559-573
- https://doi.org/10.2165/00019053-199814050-00007
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Economics of Osteoporosis and Its PreventionPharmacoEconomics, 1997
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995
- Meta-analytic Tools for Medical Decision Making: A Practical GuideMedical Decision Making, 1995
- Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post‐menopausal osteoporosisClinical Endocrinology, 1994
- Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapyThe American Journal of Medicine, 1993
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992
- Treatment of Postmenopausal Osteoporosis with Transdermal EstrogenAnnals of Internal Medicine, 1992
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- Postmenopausal OsteoporosisMedical Clinics of North America, 1987
- Cost-Effectiveness of Hormone Replacement Therapy in the MenopauseObstetrical & Gynecological Survey, 1983